Add to ORKGThe EORTC Lung Working Party is a regional cooperative group that has investigated various chemotherapeutic regimens in patients with small cell lung cancer. Results of the CAV, AVE and CAVE studies are summarized as well as the pilot study of late intensification in this type of patients.SCOPUS: NotDefined.jinfo:eu-repo/semantics/publishe
Introduction: The lung cancers are among the five most frequent cancers (and incidence continues to ...
Das Bronchialkarzinom ist heute der häufigste Tumor des Mannes und einer der häufigsten bei der Frau...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
The European Lung Cancer Working Party has investigated prognostic factors for response, overall sur...
Multiple-drug chemotherapy has markedly improved the survival of patients with non oat-cell bronchia...
219 cases of small cell carcinoma of the lung are reviewed. The 5-year survival rate is less than 5%...
The precocity of the diagnosis of non small lung cancers (NSCLC) is crucial. Only 30% of these tumou...
Aims. We have audited the changes in treatment practice for small-cell lung cancer (SCLC) presented ...
ERS Annual Congress, Madrid, Espagneinfo:eu-repo/semantics/publishedsuppl 30,433s (P2912
AbstractThe EORTC Lung Cancer Group (LCG) maintains a multidisciplinary clinical trial portfolio. Ov...
Le cancer du poumon représente la première cause de mortalité par cancer en France ainsi qu'au nivea...
These updated clinical practice guidelines on the treatment of small cell lung cancer (SCLC) limited...
OBJECTIVE: The aim of the study is to analyse long-term results of patients with small cell lung can...
Item does not contain fulltextThe EORTC Leukemia Group comprises more than 45 qualified haematology ...
Les cancers broncho-pulmonaires sont, toujours en 2010, la principale cause de décès par cancer dans...
Introduction: The lung cancers are among the five most frequent cancers (and incidence continues to ...
Das Bronchialkarzinom ist heute der häufigste Tumor des Mannes und einer der häufigsten bei der Frau...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
The European Lung Cancer Working Party has investigated prognostic factors for response, overall sur...
Multiple-drug chemotherapy has markedly improved the survival of patients with non oat-cell bronchia...
219 cases of small cell carcinoma of the lung are reviewed. The 5-year survival rate is less than 5%...
The precocity of the diagnosis of non small lung cancers (NSCLC) is crucial. Only 30% of these tumou...
Aims. We have audited the changes in treatment practice for small-cell lung cancer (SCLC) presented ...
ERS Annual Congress, Madrid, Espagneinfo:eu-repo/semantics/publishedsuppl 30,433s (P2912
AbstractThe EORTC Lung Cancer Group (LCG) maintains a multidisciplinary clinical trial portfolio. Ov...
Le cancer du poumon représente la première cause de mortalité par cancer en France ainsi qu'au nivea...
These updated clinical practice guidelines on the treatment of small cell lung cancer (SCLC) limited...
OBJECTIVE: The aim of the study is to analyse long-term results of patients with small cell lung can...
Item does not contain fulltextThe EORTC Leukemia Group comprises more than 45 qualified haematology ...
Les cancers broncho-pulmonaires sont, toujours en 2010, la principale cause de décès par cancer dans...
Introduction: The lung cancers are among the five most frequent cancers (and incidence continues to ...
Das Bronchialkarzinom ist heute der häufigste Tumor des Mannes und einer der häufigsten bei der Frau...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...